With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford||Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D.||Phase I/II Infrastructure Grants||2015||California|
|Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML||Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD||Reach Grants||2015||California|
|Single Cell Analysis of Leukemia Initiation||Stanford University / Michael Cleary, MD||Innovation Grants||2015||California|
|Genetic Dissection of Cancer Drug Resistance and Toxicity Using Haploid Human Cells||Stanford University / Ramin Dubey, PhD||Young Investigator Grants||2015||California|
|Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia||Boston Children's Hospital / Alan Cantor, MD, PhD||Innovation Grants||2015||Massachusetts|
|Regulation of Hematopoietic Stem Cell Engraftment by the Endothelial Cell Niche||Boston Children's Hospital / Bradley Blaser, MD, PhD||Young Investigator Grants||2015||Massachusetts|
|Engager T Cells: A Novel Immunotherapeutic for AML||University of Michigan / Challice Bonifant, MD, PhD||Young Investigator Grants||2015||Michigan|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|
|Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma||Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)||Innovation Grants||2015||Virginia|
|Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified||Broad Institute / Rameen Beroukhim, MD,PhD||Innovation Grants||2015||Massachusetts|